Inventor · disambiguated record
Jeffrey T. Blue
Also filed as: BLUE JEFFREY T · BLUE JEFFREY THOMAS
8 granted patents·12 pending applications·279 citations·filing 1997–2023
88Inventor score
Files withMERCK SHARP & DOHME6CONDRA JON H4MERCK SHARP & DOHME LLC4BHAMBHANI AKHILESH1BLUE JEFFREY T1
Top patents by PatentIndex Score
20 records- 0195US8188233B21B20 PCSK9 antagonistsCONDRA JON H·Filed 2009·Granted May 29, 2012·91 cites·22 claims
- 0295US8188234B21D05 PCSK9 antagonistsCONDRA JON H·Filed 2009·Granted May 29, 2012·98 cites·19 claims
- 0389US11883480B2Formulations of dengue virus vaccine compositionsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 30, 2024·2 cites·8 claims
- 0489US8697070B21D05 PCSK9 antagonistsCONDRA JON H·Filed 2012·Granted Apr 15, 2014·15 cites·6 claims
- 0589US8192746B215-valent pneumococcal polysaccharide-protein conjugate vaccine compositionCAULFIELD MICHAEL J·Filed 2011·Granted Jun 5, 2012·51 cites·7 claims
- 0678US12208135B2Formulations of dengue virus vaccine compositionsMERCK SHARP & DOHME LLC·Filed 2023·Granted Jan 28, 2025·0 cites·5 claims
- 0773US8957194B21B20 PCSK9 antagonistsCONDRA JON H·Filed 2012·Granted Feb 17, 2015·2 cites·7 claims
- 0864US2023277654A1Stable formulations of cytomegalovirusMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0962US2022105169A1Pneumococcal conjugate vaccine formulationsMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1060US5861297ADetergent-free hepatitis C proteaseMERCK & CO INC·Filed 1997·Granted Jan 19, 1999·20 cites·3 claims
- 1156US2014220027A11d05 pcsk9 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1254US2021299247A1Stable formulations of cytomegalovirusMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 1354US2020360500A1Pneumococcal conjugate vaccine formulationsCHINTALA RAMESH V·Filed 2018·Application pending·0 cites
- 1453US2023288140A1Apparatus and method of microwave vacuum drying sterile productsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1549US2016375133A1Methods for producing high concentration lyophilized pharmaceutical formulationsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 1647US2020390877A1Formulations of dengue virus vaccine compositionsRYAN MICHAEL S·Filed 2018·Application pending·0 cites
- 1747US2012121580A1Methods for producing high concentration lyophilized pharmaceutical formulationsBHAMBHANI AKHILESH·Filed 2010·Application pending·0 cites
- 1844US2017340738A1Stable acidic insulin formulationsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1943US2020181678A1Cell-Based Reporter Assay for Live Virus VaccinesMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2035US2013273098A1Novel formulations which mitigate agitation-induced aggregation of immunogenic compositionsBLUE JEFFREY T·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →